CravingWise methodology: how we evaluate GLP-1 price and provider information

Source standards and evidence

CravingWise relies on public primary sources, manufacturer published pricing pages, and official regulatory guidance when reporting on GLP-1 medications and related services. We only use facts explicitly present in the sources we cite. For prescription-drug facts and safety information we prioritize U.S. federal agencies (for example, the FDA) and manufacturers' official communications. We separate FDA-approved branded GLP-1 medications from compounded or unapproved products and explicitly note regulatory warnings when present.

• We use FDA guidance and alerts for safety information (for example, FDA pages about unapproved GLP-1 products). See the FDA warning on unapproved GLP-1 drugs: FDA notice
• For manufacturer pricing or program terms we cite the company page directly (for example, NovoCare and Lilly). See NovoCare pricing: NovoCare pricing page and Lilly Zepbound pricing: Lilly pricing page
• For online pharmacy safety recommendations we cite FDA consumer guidance such as BeSafeRx: FDA BeSafeRx

Ranking policy and comparison methodology

When we compare providers, platforms, or pricing options, we apply a consistent set of ranking factors so readers can compare like with like. Our methodology is intended to make transparent which aspects we consider and how they affect placement in comparison lists.

• Clear separation of costs: we list medication cash-price separately from any membership, telehealth, or platform fees.
• Regulatory status: FDA-approved branded medications are flagged and separated from compounded or unapproved products and any safety warnings are surfaced prominently.
• Source currency: we prefer manufacturer or official pages that publish current prices or program terms, and we display the URL and last verified date for each such source.
• Provider transparency: we favor providers that publish licensing, clinician credentials, clear refund or cancellation terms, and accessible safety information.

How we handle price data

Price information for prescription medications can change frequently. When we report prices we follow these rules to avoid misleading readers:

• We only publish prices that are explicitly stated on primary source pages (for example, manufacturer or pharmacy pages).
• We state the effective or last-verified date for price pages. Where a brand or program publishes dose-specific pricing (for example, Lilly's Zepbound price listings), we cite that page directly: Lilly pricing page
• We separate manufacturer cash-pay or pharmacy prices from any platform or membership fees (for example, NovoCare's published pharmacy pricing and program terms are cited separately: NovoCare pricing page).
• We do not invent or estimate prices, nor do we aggregate unaudited third-party price lists into a single average without clear sourcing.

Safety, FDA warnings, and unapproved products

Safety summaries on CravingWise are based on official regulatory communications and manufacturer safety information. We surface FDA warnings and explain their relevance to consumers considering GLP-1 medications.

• We call out FDA advisories about unapproved GLP-1 products, dosing errors, and adverse events. See FDA concerns about unapproved GLP-1 drugs: FDA notice
• We include the FDA's guidance for buying medicines online and recommend readers verify online pharmacies before purchasing: FDA BeSafeRx
• We do not endorse or list products described as "for research use only" or otherwise presented as not for human use; such products are flagged and treated as unapproved when they are marketed to consumers.

Advertising, affiliate, and paid placement policy

CravingWise accepts advertising and may participate in affiliate programs. We keep editorial content separate from sponsored content and disclose commercial relationships clearly near relevant pages. Our policies are:

• Affiliate and advertising relationships are disclosed on pages where links may generate revenue.
• Affiliate revenue does not influence our fact-checking standards: any claim in editorial content must be traceable to an approved source listed in that piece.
• Paid placement or sponsored listings are clearly labeled as advertising or 'sponsored' and are not mixed into organic editorial rankings without disclosure.

Corrections and updates policy

We aim to keep pages current and accurate. If readers or sources notify us of an error, we investigate and correct factual mistakes promptly. Corrections include a brief note on the page indicating what changed and when.

• Report errors using our contact link on the site; we will confirm receipt and provide an expected timeline for review.
• When a correction is made we add a short note summarizing the correction and the date it was implemented.
• For substantive changes (for example, changes in manufacturer pricing or major regulatory actions) we update the article and the 'last verified' date.

Medical and legal disclaimers

CravingWise provides general information and does not provide personalized medical advice. We do not give dosing instructions, clinical recommendations, or replace clinical judgment. Readers are encouraged to consult qualified clinicians and verify prescription requirements and safety information.

• Medical disclaimer: Content is for informational purposes only and is not medical advice. Talk with a licensed health care professional before starting or stopping any medication.
• Legal and regulatory note: We separate FDA-approved branded medications from compounded or unapproved products and report regulatory warnings from the FDA where relevant.
• Purchasing advice: Verify any online pharmacy with official guidance such as the FDA's BeSafeRx resource: FDA BeSafeRx

Transparency about sources and verification

Each article that reports prices, program terms, or safety information includes visible source URLs and a 'last verified' date. We cite manufacturer pages for pricing and FDA pages for safety advisories whenever those are the primary source.

• Examples of primary sources we cite in GLP-1 coverage: NovoCare pharmacy pricing: NovoCare pricing page; Lilly Zepbound pricing: Lilly pricing page; FDA GLP-1 warnings: FDA notice
• All price and safety facts on CravingWise are traceable to the URLs shown on the page and the listed 'last verified' date.

Questions People Ask